Here's your executive in charge of Amarex; Mr. M
Post# of 148050
Mr. Martin Lush, A Masters degree in Medical Microbiology.
Worked at Proctor and Gamble as a senior research scientist.
worked at Astra Zeneca as the Manufacturing Plant Manager.
Worked at NSF since 2008 as Senior Partner.
Worked at NSF as Vice-president.
Worked at NSF as President. since 2014 and is currently the Global VP of pharma, Biotech and Medical Devices.
He was in the room when they acquired Amarex (he was an adviser on M&A).
He is a disciple of disruptive thinking. Wonder IF he's given any thought to how disruptive VYROlogix may become.
Something I am not understanding,...IF he believed WE own the data in question since his email of June 9th, 2021...and likely sooner.
WHY does it take almost 4 months to the day to get our hands on it. Martin Lush has worked in hospital settings and presumably understands what's at stake.